ResearcherSoutheast UniversityActive in the last 2 years

Shaohua Gou

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0003-0284-5480; OpenAlex author ID A5084495143.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2026: 2 papers

Papers 2

Brigatinib-based targeted drug conjugates afford selective and potent anti-tumor efficacy in the treatment of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bioorg.2026.110247 ↗
Scaffold hopping-directed design and discovery of N1-substituted aminopyrimidine-indole derivatives as FAK inhibitors with anti-pancreatic cancer activity. Last author DOI 10.1016/j.bmc.2026.118753 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Libo Cai · 1 shared paper, 2026
- Paper Scaffold hopping-directed design and discovery of N1-substituted aminopyrimidine-indole derivatives as FAK inhibitors w… DOI 10.1016/j.bmc.2026.118753 ↗
Heng Zhang · 1 shared paper, 2026
- Paper Brigatinib-based targeted drug conjugates afford selective and potent anti-tumor efficacy in the treatment of pancreati… DOI 10.1016/j.bioorg.2026.110247 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.